Clinical Trend of the Week (November 11-17): Alagille Syndrome
Promising research involving a rare condition resulted in this week's top search term. Alagille syndrome is a genetic disorder that is characterized by liver damage that involves the bile ducts. Findings from a phase 2 study that evaluated the efficacy and safety of an apical sodium-dependent bile acid transporter inhibitor used to treat Alagille syndrome were recently presented at The Liver Meeting 2017: American Association for the Study of Liver Diseases. Separate research using zebrafish identified tissues and genes that are crucial to liver duct development; further investigations will explore potential regenerative therapies designed to restore function and possibly prevent the need for liver transplant in some patients with Alagille syndrome. Although both sets of findings are preliminary, optimism for future treatments and therapy for this rare condition resulted in this week's top search term.
For more information on Alagille syndrome, read here.
Medscape © 2017
WebMD, LLC
Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.
Cite this: Ryan Syrek. Clinical Trends for November 2017 - Medscape - Dec 01, 2017.
Comments